Barclays PLC Sponsored ADR (BCS) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 26	$0.74	$0.76	+2.7%	—	$8.2B	—
Q4 25	$0.43	$0.49	+14.0%	—	$7.1B	—
Q3 25	$0.54	$0.56	+3.7%	—	$7.2B	—
Q2 25	$0.6	$0.63	+5.0%	—	$7.2B	—
Q1 25	$0.61	$0.69	+13.1%	—	$7.7B	—
Q4 24	$0.19	$0.21	+10.5%	—	$8.7B	—
Q3 24	—	$0.56	—	—	$8.6B	—
Q2 24	$0.4	$0.42	+5.0%	—	$6.3B	—
Q1 24	$0.45	$0.51	+13.3%	—	$7B	—
Q4 23	-$0.13	$0.16	+223.1%	—	$5.6B	—
Q1 23	—	$0.58	—	—	$7.2B	—
Q4 22	—	$0.3	—	—	$5.8B	—
Q3 22	—	$0.44	—	—	$6B	—
Q2 22	—	$0.27	—	—	$6.7B	—
Q1 22	—	$0.45	—	—	$6.5B	—
Q4 21	—	$0.36	—	—	$5.2B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$1.75	—	—	$29.1B	—
FY24	—	$1.44	—	—	$35.7B	—
FY23	—	$1.11	—	—	$25.4B	—
FY22	—	$1.23	—	—	$24.7B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$21.4B	$21.1B	$21.1B	$21.6B	$21.6B	$22B	$24.7B	$25.4B	$35.7B	$29.1B
YoY change	-2.69%	-1.67%	+0.28%	+2.33%	-0.05%	+1.57%	+12.6%	+2.65%	+40.6%	-18.4%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	21.4B	21.1B	21.1B	21.6B	21.6B	22B	24.7B	25.4B	35.7B	29.1B
Cost of revenue	—	—	—	—	—	—	—	—	—	—
Gross profit	—	—	—	—	—	—	—	—	—	—
Gross margin	—	—	—	—	—	—	—	—	—	—
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	2.1B	2.4B	2.2B	2.1B	2B	2B	2.3B	2.6B	3.8B	2.7B
Operating expenses	2.6B	2.7B	2.5B	2.3B	2.3B	2.1B	2.3B	2.1B	3.8B	2.8B
Operating income	—	—	—	—	—	—	—	—	—	—
Operating margin	—	—	—	—	—	—	—	—	—	—
Non-operating income, net	—	—	—	—	—	—	—	—	—	—
Pretax income	3.2B	3.5B	3.5B	4.4B	3.1B	8.2B	7B	6.6B	11B	9.1B
Income tax	993M	2.1B	911M	1B	604M	1.1B	1B	1.2B	2.4B	1.9B
Net income	2.8B	-720M	2.6B	3.4B	2.5B	7.1B	6B	5.3B	8.6B	7.2B
Net margin	13.2%	-3.42%	12.2%	15.5%	11.4%	32.1%	24.2%	21%	24.2%	24.8%
EBITDA	—	—	—	—	—	—	—	—	—	—
EPS	0.42	-0.41	0.38	0.57	0.35	1.5	1.23	1.11	1.44	1.75
Diluted EPS	0.41	-0.41	0.37	0.56	0.34	1.46	1.19	1.08	1.39	1.69

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	6.3B	5.6B	7B	6.3B	8.6B	8.7B	7.7B	7.2B	7.2B	7.1B	8.2B	8.3B
Cost of revenue	—	—	—	—	—	—	—	—	—	—	—	—
Gross profit	—	—	—	—	—	—	—	—	—	—	—	—
Gross margin	—	—	—	—	—	—	—	—	—	—	—	—
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	—	—	—	—	—	—	—	—	—	—	—	—
Operating expenses	3.9B	-12.5B	4.1B	-4B	5.2B	-16.3B	4.4B	-4.3B	4.2B	-12.7B	4.4B	4.5B
Operating income	—	—	—	—	—	—	—	—	—	—	—	—
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—
Non-operating income, net	—	—	—	—	—	—	—	—	—	—	—	—
Pretax income	1.9B	110M	2.3B	1.9B	2.9B	2.3B	2.7B	2.5B	2.1B	1.9B	2.8B	3.3B
Income tax	343M	-23M	465M	427M	542.4M	609.7M	621M	552M	365M	388M	638M	731M
Net income	1.5B	133M	1.8B	1.5B	2.4B	1.7B	2.1B	1.9B	1.7B	1.5B	2.2B	2.5B
Net margin	24.6%	2.37%	26.1%	23.9%	27.8%	18.9%	27.2%	26.9%	23.9%	20.8%	26.7%	30.2%
EBITDA	—	—	—	—	—	—	—	—	—	—	—	—
EPS	0.33	—	0.41	—	0.43	0.27	0.52	—	0.42	0.34	0.56	0.67
Diluted EPS	0.33	—	0.41	—	0.43	0.27	0.52	—	0.42	0.34	0.56	0.67

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	37.4B	37.3B	26B	33B	27.9B	35.4B	25.7B	24.3B	—	—	—
Enterprise value	34.4B	6B	-1.6B	28.4B	-19.2B	-36.5B	-47.3B	-23.8B	—	—	—
Shares outstanding	3.4B	3.4B	3.4B	3.5B	3.5B	3.4B	3.3B	3.1B	5B	3.5B	3.5B

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	13.2	—	10	9.84	11.3	5.02	4.3	4.56	—	—	—
P/S	1.74	1.77	1.23	1.53	1.29	1.61	1.04	0.96	—	—	—
P/B	0.52	0.57	0.41	0.5	0.42	0.51	0.37	0.34	—	—	—
EV/Sales	1.6	0.28	-0.08	1.31	-0.89	-1.66	-1.91	-0.94	—	—	—
Earnings yield	7.56%	—	9.95%	10.2%	8.83%	19.9%	23.3%	21.9%	—	—	—
FCF yield	25.6%	158.7%	30%	-6.95%	201.6%	133.2%	110.9%	-10.9%	—	—	—

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Net margin	13.2%	-3.42%	12.2%	15.5%	11.4%	32.1%	24.2%	21%	24.2%	24.8%	24.8%
ROE	3.96%	-1.09%	4.05%	5.11%	3.68%	10.1%	8.62%	7.41%	8.77%	9.22%	9.22%
ROA	—	—	—	—	—	—	—	—	0.42%	0.47%	0.47%
Return on tangible assets	—	—	—	—	—	—	—	—	0.42%	0.47%	0.47%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Debt / equity	1.39	2.12	2.34	2.22	2.15	2.38	2.65	2.46	2.56	2.81	2.81
Debt / assets	—	—	—	—	—	—	—	—	0.12	0.14	0.14
Effective tax rate	30.7%	58.3%	26.1%	23%	19.7%	13.9%	14.8%	18.8%	21.6%	21.1%	21.1%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	6.3	6.15	6.14	6.24	6.2	6.41	7.51	8.24	7.11	8.26	8.26
EPS (basic)	0.42	-0.41	0.38	0.57	0.35	1.5	1.23	1.11	1.44	1.75	1.75
EPS (diluted)	0.41	-0.41	0.37	0.56	0.34	1.46	1.19	1.08	1.39	1.69	1.69
Book value per share	21	19.3	18.5	18.9	19.2	20.5	21	23.3	19.6	22.2	22.2
FCF per share	2.82	17.3	2.26	-0.66	16.1	13.8	8.65	-0.86	1.5	4.78	4.78
Cash per share	30.1	49.9	51.4	43.3	54.8	69.7	77.9	72.9	57	65.1	65.1
Capex per share	0.4	0.34	0.4	0.5	0.38	0.5	0.53	0.56	0.43	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	6.29%	5.57%	6.55%	8.08%	6.13%	7.83%	7.06%	6.77%	6%	—	—
Capex / operating cash flow	-6.39%	2.81%	-6.64%	137.1%	27.1%	-33.5%	-9.92%	3.22%	-49.8%	—	—
Payout ratio	46.1%	-176.8%	64.2%	57%	38%	19.3%	33.1%	42.4%	35.6%	31.2%	31.2%
Dividend yield	3.49%	3.41%	6.39%	5.79%	3.36%	3.84%	7.7%	9.3%	—	—	—

Yield

—

trailing twelve months

Frequency

Semi-annual

Last dividend

$0.313

ex-dividend Aug 7, 2026

Payout ratio

31%

of earnings

Dividend growth

4 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 7, 2026	$0.313
Feb 20, 2026	$0.307
Aug 8, 2025	$0.16

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$6.3B	$5.6B	$7B	$6.3B	$8.6B	$8.7B	$7.7B	$7.2B	$7.2B	$7.1B	$8.2B	$8.3B
YoY change	+5.16%	-3.25%	-3.92%	+0.62%	+37.7%	+55.6%	+10.9%	+13.6%	-16.8%	-18.8%	+5.89%	+16%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	102.4B	171.1B	177.1B	150.3B	191.1B	238.6B	256.4B	224.6B	286B	229.8B
Receivables	—	—	—	—	—	—	—	—	—	—
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	—	—	—	—	—	—	—	—	—	—
Property, plant & equipment	6.6B	5.2B	5.5B	7.2B	4B	-2.5B	-1.9B	-2.2B	-3.1B	-2.1B
Goodwill & intangibles	15.5B	15.7B	15.9B	16.2B	15.9B	16.1B	16.5B	15.6B	22.5B	16.6B
Total assets	—	—	—	—	—	—	—	—	2.1T	1.5T
Accounts payable	—	—	—	—	—	—	—	—	—	—
Short-term debt	—	—	—	—	—	—	—	—	—	—
Total current liabilities	—	—	—	—	—	—	—	—	—	—
Long-term debt	99.3B	139.7B	149.5B	145.6B	144B	166.6B	183.4B	176.6B	252.8B	219.9B
Total liabilities	—	—	—	—	—	—	—	—	2T	1.5T
Shareholders' equity	71.4B	66B	63.8B	65.7B	66.9B	70B	69.3B	71.9B	98.6B	78.2B
Total debt	99.3B	139.7B	149.5B	145.6B	144B	166.6B	183.4B	176.6B	252.8B	219.9B
Net debt	-3B	-31.4B	-27.6B	-4.6B	-47.1B	-72B	-73B	-48.1B	-33.3B	-9.8B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	262.8B	224.6B	251.3B	243.5B	283.1B	286B	239.5B	225.7B	237.4B	229.8B	235.3B	245.9B
Receivables	—	—	—	—	—	—	—	—	—	—	—	—
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	—	—	—	—	—	—	—	—	—	—	—	—
Property, plant & equipment	—	-2.2B	—	—	—	-3.1B	—	—	—	-2.1B	—	—
Goodwill & intangibles	8.3B	15.6B	7.8B	7.8B	10.7B	22.5B	8.3B	8.2B	8.3B	16.6B	8.4B	8.9B
Total assets	—	—	1.6T	1.6T	2T	2.1T	1.6T	1.6T	1.6T	1.5T	1.7T	1.7T
Accounts payable	—	—	—	—	—	—	—	—	—	—	—	—
Short-term debt	—	—	—	—	—	—	—	—	—	—	—	—
Total current liabilities	—	—	—	—	—	—	—	—	—	—	—	—
Long-term debt	114B	176.6B	118.8B	108.6B	132.6B	252.8B	110.5B	117.4B	121.5B	219.9B	136.8B	137.9B
Total liabilities	—	—	—	1.5T	1.9T	2T	1.5T	1.5T	1.6T	1.5T	1.6T	1.7T
Shareholders' equity	69B	71.9B	72.3B	71.8B	94.3B	98.6B	75.5B	76.4B	76.8B	78.2B	77.1B	79.8B
Total debt	114B	176.6B	118.8B	108.6B	132.6B	252.8B	110.5B	117.4B	121.5B	219.9B	136.8B	137.9B
Net debt	-148.8B	-48.1B	-132.5B	-134.9B	-150.5B	-33.3B	-129B	-108.3B	-115.9B	-9.8B	-98.5B	-107.9B

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	3.2B	3.5B	3.5B	4.4B	3.1B	8.2B	7B	6.6B	11B	9.1B
Depreciation & amortization	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	—	—
Change in working capital	-4.3B	37.2B	-19.8B	-2.8B	4.8B	-16.4B	-11.3B	36.1B	-18.6B	21.4B
Operating cash flow	-21.1B	41.7B	-20.8B	1.3B	4.9B	-5.1B	-17.6B	53.4B	-4.3B	18.7B
Capital expenditure	-1.3B	-1.2B	-1.4B	-1.7B	-1.3B	-1.7B	-1.7B	-1.7B	-2.1B	—
Investing cash flow	36.7B	3.5B	1.2B	-24B	-18.4B	4.3B	-21.7B	-23.4B	-24.3B	3.5B
Dividends paid	-1.3B	-1.3B	-1.7B	-1.9B	-936M	-1.4B	-2B	-2.3B	-3.1B	-2.3B
Share repurchases	-1.7B	-1.9B	-4.1B	-3.1B	-1.4B	-1.7B	-4.1B	-5.2B	-6.9B	-6.2B
Financing cash flow	-1.3B	961M	-6.8B	690M	2.7B	107M	696M	-1.4B	1.1B	2.3B
Net change in cash	14.3B	46.2B	-26.4B	-22B	-10.8B	-760M	-38.6B	28.6B	-27.6B	24.4B
Free cash flow	9.6B	59.3B	7.8B	-2.3B	56.2B	47.2B	28.5B	-2.6B	7.5B	16.9B

Date	Ratio
Feb 19, 2014	74:73
Sep 19, 2013	1085:1000
May 6, 2002	4:1
Jun 8, 1990	7:5

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Split history

Barclays PLC Sponsored ADR Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Split history